Comparison of the therapeutic effects of minoxidil solution alone with the combination of minoxidil and flutamide solution in patients with androgenic alopecia

Phase 3

Recruiting

• Conditions: Androgenic alopecia.; Androgenic alopecia, unspecified; L64.9

• Registration Number: IRCT20200825048515N6
• Lead Sponsor: Esfahan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 9 November 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

Confirmation of androgenic alopecia by two experienced dermatologists based on Hamilton diagnostic criteria
Patient consent to participate in the study
The intensity of hair loss in stage 2 to 5 according to Hamilton scale and in stages 1 and 2 according to Ludwig scale
The duration of hair loss is less than 10 years

Exclusion Criteria

History or observation of allergies to any of the drugs minoxidil and flutamide
History of heart disease and use of antihypertensive drugs
Receiving systemic treatment for androgenic alopecia during the 6 months prior to the study
Other types of alopecia such as alopecia areata, telogen effluvium, anagen effluvium and scarring alopecia of any systemic cutaneous disease

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Hair density. Timepoint: Pre-and post-intervention. Method of measurement: Hair polarizer.;Severity of hair loss. Timepoint: Pre-and post-intervention. Method of measurement: By a skilled physician based on Hamilton-Norwood scale for male pattern hair loss and Ludwig scale for female pattern hair loss.